Skip to main content
. 2023 Jun 14;18(1):31. doi: 10.5334/gh.1211

Table 1.

Basal characteristics, risk factors and socioeconomic factors of all patients in both groups.


GROUP I (N = 842) (CONTROLLED HTN) GROUP II (N = 148)(RESISTANT HTN) P. VALUE

Age, years 61.01 ± 11.02 62.94 ± 10.89 0.049*

Male gender, n (%) 437 (51.9%) 80 (54.1%) 0.629

Smoking, n (%) 299 (35.5%) 49 (33.1%) 0.572

Diabetes, n (%) 261 (31.0%) 51 (34.5%) 0.403

Dyslipidemia, n (%) 307 (36.5%) 52 (35.1%) 0.757

Cardiovascular diseases, n (%) 159 (18.9%) 30 (20.3%) 0.692

Chronic Kidney diseases, n (%) 168 (20.0%) 41 (27.7%) 0.033*

Cerebrovascular diseases, n (%) 80 (9.5%) 19 (12.8%) 0.212

Peripheral vascular diseases, n (%) 102 (12.1%) 24 (16.2%) 0.167

Obstructive sleep apnea, n (%) 44 (5.2%) 14 (9.5%) 0.043*

Obesity, n (%) 172 (20.4%) 42 (28.4%) 0.030*

Family history of high blood pressure, n (%) 271 (32.2%) 48 (32.4%) 0.953

Lack of physical activity, n (%) 448 (53.2%) 86 (58.1%) 0.270

Atrial fibrillation, n (%) 109 (12.9%) 25 (16.9%) 0.196

Non-steroidal anti-inflammatory drugs use, n (%) 136 (16.2%) 34 (23.0%) 0.042*

Antidepressant drugs use, n (%) 50 (5.9%) 6 (4.1%) 0.360

Corticosteroid drugs use, n (%) 52 (6.2%) 12 (8.1%) 0.378

Cholesterol lowering medication use, n (%) 442 (52.5%) 72 (48.6%) 0.388

Antiplatelet medication use, n (%) 377 (44.8%) 64 (43.2%) 0.730

Diuretics, n (%) 601 (71.4%) 148 (100%) 0.001*

Beta-blocker, n (%) 535 (63.5%) 98 (66.2%) 0.532

ACE inhibitors OR ARB, n (%) 513 (60.9%) 133 (89.9%) 0.001*

Calcium channel blocker, n (%) 495 (58.8%) 127 (85.8%) 0.001*

Others, n (%) 245 (29.1%) 42 (28.4%) 0.859

History of non-adherence to medication, n (%) 297 (35.3%) 65 (43.9%) 0.044*

Marital status, married, n (%) 495 (58.8%) 88 (59.5%) 0.878

Income category, low income, n (%) 477 (56.7%) 89 (60.1%) 0.430

Level of education, lower, n (%) 369 (43.8%) 78 (52.7%) 0.045*

Residence, urban, n (%) 481 (57.1%) 82 (55.4%) 0.697

Occupational status, employed, n (%) 450 (53.4%) 77 (52.0%) 0.750

Health insurance, n (%) 347 (41.2%) 60 (40.5%) 0.878

Excessive salty diet, n (%) 409 (48.6%) 90 (60.8%) 0.006*

*: Significant P value, ACE: angiotensin converting enzyme; ARB, angiotensin receptor blockers.